115372 Results

People

  1. Ladanyi
    Ladanyi
  2. Motzer
    Motzer
  3. Reuter
    Reuter
  4. Scher
    Scher
  5. Brennan
    Brennan
  6. Giralt
    Giralt
  7. Gonen
    Gonen
  8. Perales
    Perales
  9. Hudis
    Hudis
  10. Jarnagin
    Jarnagin

Groups

  1. Department of Medicine (39034)
  2. GSK Faculty (22468)
  3. Solid Tumor Oncology Division (22057)
  4. Surgery (21249)
  5. Sloan Kettering Institute Faculty (16086)
  6. Survivorship Research (15763)
  7. Center for Hematologic Malignancies (13263)
  8. Hematologic Malignancies, Division of (13087)
  9. Sloan Kettering Institute Postdocs (12936)
  10. Department of Pathology and Laboratory Medicine (12615)
Formats
  1. Journal Article (66747)
  2. Meeting Abstract (33620)
  3. Book Section (5027)
  4. Review (3744)
  5. Editorial (2162)
  6. Conference Paper (1525)
  7. Correspondence (661)
  8. Guidelines (661)
  9. Research Letter (548)
  10. Miscellaneous (339)
  11. Book Whole (338)
Groups
  1. Department of Medicine (39034)
  2. GSK Faculty (22468)
  3. Solid Tumor Oncology Division (22057)
  4. Surgery (21249)
  5. Sloan Kettering Institute Faculty (16086)
  6. Survivorship Research (15763)

More Groups

People
  1. Marc Ladanyi (1327)
  2. Robert Motzer (1243)
  3. Victor Reuter (1228)
  4. Howard Scher (1130)
  5. Murray Brennan (1059)
  6. Sergio Giralt (1050)

More People

Years
  1. 2025 (1982)
  2. 2024 (5377)
  3. 2023 (5804)
  4. 2022 (6168)
  5. 2021 (5712)
  6. 2020 (5599)

More Years

Publications
  1. Journal of Clinical Oncology (8590)
  2. Blood (4950)
  3. Cancer Research (2701)
  4. International Journal of Radiation Oncology, Biology, Physics (2610)
  5. Laboratory Investigation (1879)
  6. Modern Pathology (1812)

More Publications

Publishers
  1. Elsevier Inc. (13855)
  2. American Society of Clinical Oncology (9157)
  3. Springer (7152)
  4. Nature Publishing Group (6367)
  5. American Association for Cancer Research (6002)
  6. Elsevier Science, Inc. (5503)

More Publishers

Results (115372)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Outcomes of stereotactic radiosurgery for colorectal cancer brain metastases
    Meeting Abstract

    Gui, C.; Mueller, K. D.; Eichholz, J. E.; Walch, H.; Khatri, I.; del Balzo, L.; Kemeny, N. E.; Imber, B. S.; Schultz, N.; Foote, M. B.; more...
    Radiotherapy and Oncology (2023)

    Fulltext@MSK | Save
  • Tattoo-less chest wall irradiation (VMAT) using surface imaging
    Meeting Abstract

    Mueller, B.; Song, Y.; Chia-Ko, W.; Hsu, H.; Zhai, X.; Tamas, P.; Powell, S.; McCormick, B.; Khan, A.; Hong, L.; more...
    Radiotherapy and Oncology (2023)

    Fulltext@MSK | Save
  • Growth differentiation factor 15, a potential biomarker and a therapeutic target in myeloproliferative neoplasms
    Meeting Abstract

    Uda, N. R.; Stüdle, C.; Müggler, A.; Ueltschi, O.; Brunner, M.; Silzle, T.; Joachim, W.; Leković, D.; Lee, S. J.; Vannucchi, A. M.; more...
    Swiss Medical Weekly (2023)

    Fulltext@MSK | Save
  • Variations in cumulative dose assessment in re-irradiation scenarios: A multi-centre evaluation
    Meeting Abstract

    Hardcastle, N.; Vasquez Osorio, E.; Mayo, C.; Jackson, A.; Belosi, F.; Chamberlain, M.; Thompson, C.; Palmer, C.; Solomou, N.; Hoffmann, L.; more...
    Radiotherapy and Oncology (2023)

    Fulltext@MSK | Save
  • Daratumumab plus lenalidomide and dexamethasone (D-Rd) versus lenalidomide and dexamethasone (Rd) in transplant-ineligible patients (Pts) with newly diagnosed multiple myeloma (NDMM): Clinical assessment of key subgroups of the phase 3 MAIA study
    Meeting Abstract

    Moreau, P.; Facon, T.; Usmani, S. Z.; Bahlis, N.; Raje, N.; Plesner, T.; Orlowski, R. Z.; Basu, S.; Nahi, H.; Hulin, C.; more...
    Oncology Research and Treatment (2023)

    Fulltext@MSK | Save
  • Patterns of failure in 559 primary central nervous system lymphoma patients treated from 1983-2020
    Meeting Abstract

    Tringale, K.; Yahalom, J.; Scordo, M.; Grommes, C.; Imber, B.
    Radiotherapy and Oncology (2023)

    Fulltext@MSK | Save
  • Consolidation patterns and associated outcomes for a large cohort of primary CNS lymphoma patients
    Meeting Abstract

    Imber, B.; Tringale, K.; Scordo, M.; Yahalom, J.; Grommes, C.
    Radiotherapy and Oncology (2023)

    Fulltext@MSK | Save
  • Patient selection using genetic alterations associated with radiosensitivity in follicular lymphoma
    Meeting Abstract

    Wijetunga, N. A.; Lebow, E.; Lee, J.; Fregonese, B.; Tringale, K.; Hubbeling, H.; Sarkar, R.; Ma, J.; Seshan, V.; Joffe, E.; more...
    Radiotherapy and Oncology (2023)

    Fulltext@MSK | Save
  • Real-world treatment patterns in recurrent or advanced endometrial cancer patients on first-line systemic therapy in the United States
    Meeting Abstract

    Ogando, Y. M.; Chen, L.; Zhang, J.; Kelkar, S. S.; Prabhu, V. S.; Miles, N.; Green, A.; Makker, V.
    Pharmacoepidemiology and Drug Safety (2023)

    Fulltext@MSK | Save
  • Daratumumab plus lenalidomide and dexamethasone (D-Rd) versus lenalidomide and dexamethasone (Rd) in transplant-ineligible patients (Pts) with newly diagnosed multiple myeloma (NDMM): Clinical assessment of key subgroups of the phase 3 MAIA study
    Meeting Abstract

    Moreau, P.; Facon, T.; Usmani, S. Z.; Bahlis, N.; Raje, N.; Plesner, T.; Orlowski, R. Z.; Basu, S.; Nahi, H.; Hulin, C.; more...
    Oncology Research and Treatment (2023)

    Fulltext@MSK | Save